Finerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
NephrologyFinerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
Implications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
NephrologyImplications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
New Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
NephrologyNew Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
The Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
NephrologyThe Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
PREVENT vs PCE: Refining ASCVD Risk Prediction in Statin-Treated Populations
Heart MattersPREVENT vs PCE: Refining ASCVD Risk Prediction in Statin-Treated Populations
The LDL-C Gap in Statin-Treated Patients: A Population-Level Problem with Economic Consequences
Heart MattersThe LDL-C Gap in Statin-Treated Patients: A Population-Level Problem with Economic Consequences
- advertisement
- 5 questions
- advertisement
How GLP-1s Provide New Options to Manage Heart Disease
Medical Industry FeatureHow GLP-1s Provide New Options to Manage Heart Disease
Stroke Prevention in TAVR: Reviewing New Findings from the PROTECT-TAVI Trial
Medical Industry FeatureStroke Prevention in TAVR: Reviewing New Findings from the PROTECT-TAVI Trial
Timely LDL-C Management: Data From a Real-World Setting
Medical Industry FeatureTimely LDL-C Management: Data From a Real-World Setting
Managing LDL-C Levels and Adherence to Lipid-Lowering Therapies After a Recent Coronary Event: Putting Data Into Practice
Medical Industry FeatureManaging LDL-C Levels and Adherence to Lipid-Lowering Therapies After a Recent Coronary Event: Putting Data Into Practice
A Landmark Surgery That Saved Three Children With One Heart
Medical Industry FeatureA Landmark Surgery That Saved Three Children With One Heart
Bridging the Gap: Lipid Management in ASCVD Patients with Diabetes to Reduce CV Risk
Medical Industry FeatureBridging the Gap: Lipid Management in ASCVD Patients with Diabetes to Reduce CV Risk
- 11/10/2025
- 11/10/2025
- 11/10/2025
- 11/10/2025
- 11/10/2025
- 11/10/2025